سعر رويالسيترايد 5 مجم 30 قرص 2024

Finasteride 5 mg film-coated tablets (30 per pack) marketed in Egypt by Royal Link Pharma; a 5-alpha-reductase inhibitor used for benign prostatic hyperplasia.

• Symptomatic benign prostatic hyperplasia in men with an enlarged prostate: improves symptoms and reduces the risk of acute urinary retention and of surgery (TURP/prostatectomy).Population: Adult menDailyMed (U.S. National Library of Medicine)
• In combination with the alpha-blocker doxazosin to reduce the risk of symptomatic progression of BPH.Population: Adult menDailyMed (U.S. National Library of Medicine)

• Most common (>=1% and more than placebo): impotence, decreased libido, decreased ejaculate volume, breast enlargement, breast tenderness and rash.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Postmarketing (also with lower-dose finasteride): hypersensitivity reactions, testicular pain, haematospermia, persistent sexual dysfunction after discontinuation, male infertility/poor semen quality, depression, suicidal ideation, and rare male breast cancer.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Hypersensitivity to any component of the product.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Pregnancy: contraindicated in females who are or may potentially be pregnant (risk of abnormal external genitalia in a male fetus).International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Reduces serum PSA by about 50% within six months; establish a new PSA baseline after at least six months and evaluate any confirmed PSA increase, even within the normal range.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• May increase the risk of high-grade prostate cancer (Gleason 8-10).International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Women who are or may be pregnant should not handle crushed or broken tablets.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Contraindicated in pregnant females and not indicated in females; based on animal data and mechanism, may cause abnormal development of external genitalia in a male fetus.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Not indicated for use in females (no lactation use).International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Finasteride: Competitively inhibits type II 5-alpha-reductase, lowering conversion of testosterone to dihydrotestosterone (DHT).